Day-to-day variability in acid reflux patterns using the BRAVO pH monitoring system
- PMID: 16340628
- DOI: 10.1097/01.mcg.0000190753.25750.0e
Day-to-day variability in acid reflux patterns using the BRAVO pH monitoring system
Abstract
Background & goals: The wireless pH monitoring system such as the BRAVO pH system is a significant advancement in the evaluation of patients with gastroesophageal reflux because of its potentially better tolerability and the ability to record data over a 48-hour period. The aim of our study was to evaluate safety, performance, tolerability, and day-to-day variability in acid reflux patterns using the BRAVO pH system.
Methods: A total of 90 consecutive patients (48 men and 42 women) with persistent reflux symptoms underwent BRAVO pH capsule placement from October 2002 to August 2003 at a tertiary care hospital. The BRAVO pH capsule was deployed 6 cm proximal to the squamocolumnar junction under endoscopic guidance. The pH recordings over 48 hours were obtained after uploading data to a computer from the pager-like device that recorded pH signals from the BRAVO pH capsule.
Results: Successful pH data over 48 hours was obtained in 90% of patients. Nearly two thirds of patients experienced a variety of symptoms ranging from a foreign body sensation to chest discomfort or pain. Four patients had severe chest pain, 3 of whom required endoscopic removal of the BRAVO pH capsule. In 74.4% of patients, number of reflux events as well as time (%) pH<4 correlated from the first 24-hour period to the second 24-hour period. However, in 28% of patients, no predictable pattern of (%) time pH<4 in the supine position was reproduced from one 24-hour period to the next 24-hour period.
Conclusions: The BRAVO pH system appears a safe and effective method of recording esophageal acid exposure. It is an acceptable alternative for patients who are unwilling or unable to tolerate nasopharyngeal catheter-based pH studies, and it has a potential advantage of the 2-day recording period.
Similar articles
-
Impact of prolonged 48-h wireless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptoms and reflux episodes.Arq Gastroenterol. 2011 Jan-Mar;48(1):24-9. doi: 10.1590/s0004-28032011000100006. Arq Gastroenterol. 2011. PMID: 21537538
-
Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico.Am J Gastroenterol. 2005 Nov;100(11):2382-6. doi: 10.1111/j.1572-0241.2005.00292.x. Am J Gastroenterol. 2005. PMID: 16279888
-
[Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].Z Gastroenterol. 2009 Apr;47(4):351-6. doi: 10.1055/s-2008-1027945. Epub 2009 Apr 8. Z Gastroenterol. 2009. PMID: 19358061 Clinical Trial. German.
-
Review article: oesophageal pH monitoring--technologies, interpretation and correlation with clinical outcomes.Aliment Pharmacol Ther. 2005 Dec;22 Suppl 3:2-9. doi: 10.1111/j.1365-2036.2005.02710.x. Aliment Pharmacol Ther. 2005. PMID: 16303031 Review.
-
The Bravo pH capsule system.Dig Liver Dis. 2008 Mar;40(3):156-60. doi: 10.1016/j.dld.2007.10.025. Epub 2007 Dec 21. Dig Liver Dis. 2008. PMID: 18096447 Review.
Cited by
-
WIRELESS PH MONITORING AND CONVENTIONAL ESOPHAGEAL PH MONITORING: COMPARATIVE STUDY OF DISCOMFORT, LIMITATIONS IN DAILY ACTIVITIES AND COMPLICATIONS.Arq Bras Cir Dig. 2021 May 14;34(1):e1566. doi: 10.1590/0102-672020210001e1566. eCollection 2021. Arq Bras Cir Dig. 2021. PMID: 34008710 Free PMC article.
-
Esophageal Impedance Monitoring: Clinical Pearls and Pitfalls.Am J Gastroenterol. 2016 Sep;111(9):1245-56. doi: 10.1038/ajg.2016.256. Epub 2016 Jun 21. Am J Gastroenterol. 2016. PMID: 27325223 Review.
-
Clinical role of ambulatory reflux monitoring in PPI non-responders: recommendation statements.Aliment Pharmacol Ther. 2022 Oct;56(8):1274-1283. doi: 10.1111/apt.17180. Epub 2022 Aug 16. Aliment Pharmacol Ther. 2022. PMID: 35971888 Free PMC article.
-
Wireless esophageal pH capsule for patients with gastroesophageal reflux disease: a multicenter clinical study.World J Gastroenterol. 2014 Oct 28;20(40):14865-74. doi: 10.3748/wjg.v20.i40.14865. World J Gastroenterol. 2014. PMID: 25356046 Free PMC article. Clinical Trial.
-
24-h multichannel intraluminal impedance-pH monitoring may be an inadequate test for detecting gastroesophageal reflux in patients with mixed typical and atypical symptoms.Surg Endosc. 2015 Jul;29(7):1700-8. doi: 10.1007/s00464-014-3867-1. Epub 2014 Nov 15. Surg Endosc. 2015. PMID: 25398192
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical